Gemifloxacin mesylate side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Dyspnoea (difficult or laboured respiration)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Drug hypersensitivity
2. Anaphylactic reaction (serious allergic reaction)
3. Balance disorder
4. Kounis syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage)

female:

1. Balance disorder
2. Dyspnoea (difficult or laboured respiration)
3. Kounis syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage)

male:

1. Anaphylactic reaction (serious allergic reaction)

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

1. Kounis syndrome (the concurrence of heart pain with conditions associated with mast cell activation leads to heart muscle damage)

50-59:

1. Drug hypersensitivity
2. Balance disorder

60+:

1. Anaphylactic reaction (serious allergic reaction)
2. Dyspnoea (difficult or laboured respiration)